Dapsone Actavis

Dapsone Actavis

dapsone

Manufacturer:

Teva

Distributor:

Zuellig
Concise Prescribing Info
Contents
Dapsone
Indications/Uses
Leprosy; skin problems; prevention of malaria in combination w/ pyrimethamine & pneumonia in immunodeficient patients.
Dosage/Direction for Use
Adult & childn >12 yr Multibacillary leprosy 100 mg daily for at least 2 yr. Paucibacillary leprosy 100 mg daily for at least 6 mth. Malaria prophylaxis 100 mg wkly w/ 12.5 mg pyrimethamine. Dermatitis herpetiformis Initially 50 mg daily; may be gradually increased to 300 mg daily then reduced to usual maintenance dose 25-50 mg daily. Pneumocystis carinii pneumonia In combination w/ trimethoprim, 50-100 mg daily or 100 mg twice wkly or 200 mg once wkly. Childn 6-12 yr Multibacillary leprosy 50 mg daily for at least 2 yr. Paucibacillary leprosy 50 mg daily for at least 6 mth. Elderly A lower dose may be required in case of liver damage.
Administration
May be taken with or without food.
Contraindications
Hypersensitivity to dapsone or to similar medicines eg, sulphonamide or sulphone. Severe anaemia; porphyria; severe G6PD deficiency.
Special Precautions
Blood disorders; heart or lung disease. Sugar intolerance. Pregnancy & lactation.
Adverse Reactions
Rash, fever & changes in blood cells. Severe skin reactions, liver inflammation, kidney damage & mental illness.
Drug Interactions
Probenecid; rifampicin or trimethoprim.
MIMS Class
ATC Classification
J04BA02 - dapsone ; Belongs to the class of drugs used in the systemic treatment of lepra.
Presentation/Packing
Form
Dapsone Actavis tab 100 mg
Packing/Price
28's
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Sign up for free
Already a member? Sign in